The main purposes of this cohort study were to determine the risk of first-occurrence ischemic stroke associated with NSAID use and the risk of ischemic stroke associated with the use of two specific COX-2 inhibitor NSAIDs, Celecoxib, and Etoricoxib, in subjects with RA. This evidence concerns the gene PTGS2 and rheumatoid arthritis.